AABB SmartBrief

Researchers grow human thymus tissue using stem cells

17 May 2013 12:05:23 CDT

Researchers from the University of California at San Francisco grew functioning human thymus tissue using stem cells and grow -More-

The source matters when it comes to Red Blood Cell products.
Quotient sources red cells from around the world for its new antibody screens and ID panels, helping you rule out and rule in antibodies. It's variety like this that has prompted our new contracts with GPOs, including Premier, Amerinet and GSA, to save you money. Find out how the one company focused on manual testing can serve you in 2013 and beyond.

Study: Low-intensity warfarin has post-THA benefits

17 May 2013 12:05:23 CDT

Treating patients with low-intensity warfarin for six weeks before total hip arthroplasty was associated with low incidence o -More-

Collaborative effort spawns flu vaccine in one week

17 May 2013 12:05:23 CDT

Scientists at Novartis Vaccines and Diagnostics made a synthetic flu vaccine in one week -- the result of a collaboration wit -More-

CDC asks U.S. physicians to be watchful for H7N9 virus

17 May 2013 12:05:23 CDT

The CDC is asking U.S. -More-

ICU admissions from EDs up nearly 50% in U.S.

17 May 2013 12:05:23 CDT

U.S. -More-

New Audioconference: Changes to the 6th Edition of CT Standards
On Wednesday, May 22, the AABB Center for Cellular Therapies offers its next audioconference on the Changes to the 6th edition of Standards for Cellular Therapy Services. Register online today!

ReNeuron touts promising results from stem cell trial

17 May 2013 12:05:23 CDT

Researchers are set to announce positive results from a trial of ReNeuron Group's stem cell treatment for the damage caused b -More-

Poll finds differences on roles of nurse practitioners

17 May 2013 12:05:23 CDT

Majorities of nurse practitioners and doctors agreed that NPs should be allowed to practice to the full extent of their train -More-

Rib-X's skin infection drug enters late-stage study

17 May 2013 12:05:23 CDT

Rib-X Pharmaceuticals initiated a late-stage trial to assess the efficacy of a Captisol-enabled IV formulation of delafloxaci -More-

Researchers seek FDA approval for diabetes cell transplants

17 May 2013 12:05:23 CDT

A consortium led by the University of Minnesota is preparing to seek FDA approval of a potential breakthrough treatment for t -More-

FDA clarifies existing guidance on medical-device appeals

17 May 2013 12:05:23 CDT

Draft guidance issued by the FDA aims to explain its existing guidelines for medtech companies seeking to appeal the regulato -More-

FDA seeks more patient input

17 May 2013 12:05:23 CDT

The FDA is trying to engage more patients at earlier stages of the agency's decision-making processes, asking for patient inp -More-

Adventurer and subject of the film "127 Hours" Aron Ralston to speak at annual meeting opening session

17 May 2013 12:05:23 CDT

Aron Ralston will be the featured speaker at the AABB Annual Meeting & CTTXPO opening session, to be held Oct. 12 in Denver. -More-

Consultant - Cellular Therapy
AABB

Divide each difficulty into as many parts as is feasible and necessary to resolve it.

17 May 2013 12:05:23 CDT

Rene Descartes,French mathematician and philosopher -More-